Human alveolar macrophages express elafin and secretory leukocyte protease inhibitor

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Volumn 56, Issue 3-4, 2001, Pages 291-297

  Mihaila, Alina ^a   Tremblay, Guy M ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Alveolar Macrophage; Elafin; Secretory Leukocyte Protease Inhibitor

Indexed keywords

CELL STIMULATION; CONCENTRATION (PARAMETERS); CULTURE MEDIUM; ELAFIN; GENETIC TRANSCRIPTION; HYPERSENSITIVITY REACTION; LUNG ALVEOLUS MACROPHAGE; LUNG ENZYME; MACROPHAGE; MESSENGER RNA; PNEUMONIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SACCHAROPOLYSPORA RECTIVIRGULA; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR; WESTERN BLOTTING;

EID: 0035024013     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.1515/znc-2001-3-420     Document Type: Article

References (37)

1. Bourbonnais Y., Larouche C., and Tremblay G. M. (2000), Production of full-length human pre-elafin, an elastase specific inhibitor, from yeast requires the absence of a functional Yapsin 1 (Yps1p) endoprotease. Protein Expr. Purif. 20, 485-491.
2. Böhm B., Aigner T., Kinne R., and Burkhardt H. (1992), The serine-protease inhibitor of cartilage matrix is not a chondrocytic gene product. Eur. J. Biochem. 207, 773-779.
3. Cormier Y. and Schuyler M. (1992), Hypersensitivity pneumonitis. In: Pulmonary and Critical Care Medicine (Bone R. C., Dantzker D. R., George R. B., Matthay R. A., and Reynolds H. Y., ed.). Mosby Year Book, St. Louis 1-9.
4. Dijkman J. H. (1995), Antileucoprotease in the airways and emphysema. Monaldi Arch. Chest Dis. 50, 383-387.
5. Fritz H. (1988), Human mucus proteinase inhibitor (human MPI). Human seminal inhibitor I (HUSI-I), antileukoprotease (ALP), secretory leukocyte protease inhibitor (SLPI). Biol. Chem. Hoppe Seyler 369, 79-82.
6. Gipson T. S., Bless N. M., Shanley T. P., Crouch L. D., Bleavins M. R., Younkin E. M., Sarma V., Gibbs D. F., Tefera W., McConnell P. C., Mueller W. T., Johnson K. J., and Ward P. A. (1999), Regulatory effects of endogenous protease inhibitors in acute lung inflammatory injury. J. Immunol. 162, 3653-3662.
7. Griese M., Schredl M., Hochstrasser K., and Gebhard W. (1997), Cellular association of antiproteases in lavages from ventilated preterm human neonates. Am. J. Respir. Crit. Care Med. 155, 2064-2071.
8. Grobmyer S. R., Barie P. S., Nathan C. F., Fuortes M., Lin E., Lowry S. F., Wright C. D., Weyant M. J., Hydo L., Reeves F., Shiloh M. U., and Ding A. (2000), Secretory leukocyte protease inhibitor, an inhibitor of neutrophil activation, is elevated in serum in human sepsis and experimental endotoxemia. Crit. Care Med. 28, 1276-1282.
9. Jin F., Nathan C., Radzioch D., and Ding A. (1997), Secretory leukocyte protease inhibitor: A macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 88, 417-426.
10. Jin F., Nathan C. F., Radzioch D., and Ding A. (1998), Lipopolysaccharide-related stimuli induce expression of the secretory leukocyte protease inhibitor, a macrophage-derived lipopolysaccharide inhibitor. Infect. Immun. 66, 2447-2452.
11. Kawai T., Adachi O., Ogawa T., Takeda K., and Akira S. (1999), Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11, 115-122.
12. Laviolette M., Bossé M., Rocheleau H., Lavigne S., and Ferland C. (1993), Comparison of two modified techniques for purifying blood eosinophils. J. Immunol. Methods 165, 253-261.
13. McElvaney N. G. and Crystal R. G. (1997). Antiproteases and lung defense. In: The Lung. Scientific Foundations. (Crystal R. G., West J. B., Weibel E. R., and Barnes P. J., ed.). Lippincott-Raven Publishers, Philadelphia 2219-2235.
14. McLennan G., Walsh R. L., and Robinson B. W. S. (1996). Bronchoalveolar lavage. In: Immunopathology of Lung Disease (Kradin R. L. and Robinson B. W. S., ed.). Butterworth-Heinemann, Boston 529-540.
15. Molhuizen H. O. F. and Schalkwijk J. (1995), Structural, biochemical, and cell biological aspects of the serine proteinase inhibitor SKALP/elafin/ESI. Biol. Chem. Hoppe Seyler 376, 1-7.
16. Mornex J.-F., Chytil-Weir A., Martinet Y., Courtney M., LeCocq J.-P., and Crystal R. G. (1986), Expression of the alpha-1-antitrypsin gene in mononuclear phagocytes of normal and alpha-1-antitrypsin-deficient individuals. J. Clin. Invest. 77, 1952-1961.
17. Nagareda T., Takeda M., Kojima K., Tanaka A., Terada N., Yamasaki T., Nagareda T., Ueno H., and Kotoh K. (1991), Alpha-1 antichymotrypsin is increased in human alveolar macrophages by phorbol myristate acetate or lipopolysaccharide and released from these activated macrophages by glucocorticoid. J. Pathol. 165, 319-323.
18. 1-Antitrypsin: structure, function, physiology. In: Acute Phase Proteins. Molecular Biology, Biochemistry, and Clinical Applications (Mackiewicz A., Kushner I., and Baumann H., ed.). CRC Press, Boca Raton 149-167.
19. Sallenave J.-M., Shulmann J., Crossley J., Jordana M., and Gauldie J. (1994), Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am. J. Respir. Cell Mol. Biol. 11, 733-741.
20. Sallenave J.-M., Si-Ta har M., Cox G., Chignard M., and Gauldie J. (1997a), Secretory leukocyte proteinase inhibitor is a major leukocyte elastase inhibitor in human neutrophils. J. Leukoc. Biol. 61, 695-702.
21. Sallenave J.-M., Silva A., Marsden M. E., and Ryle A. P. (1993), Secretion of mucus proteinase inhibitor and elafin by Clara cell and type II pneumocyte cell lines. Am. J. Respir. Cell Mol. Biol. 8, 126-133.
22. 1-proteinase inhibitor in A549 human alveolar epithelial cells. J. Interferon Cytokine Res. 17, 337-346.
23. Sano C., Shimizu T., Sato K., Kawauchi H., and Tomioka H. (2000), Effects of secretory leucocyte protease inhibitor on the production of the anti-inflammatory cytokines, IL-10 and transforming growth factor-beta (TGF-β), by lipopolysaccharide-stimulated macrophages. Clin. Exp. Immunol. 121, 77-85.
24. Schalkwijk J., Wiedow O., and Hirose S. (1999), The trappin gene family: proteins defined by an N-terminal transglutaminase substrate domain and a C-terminal four-disulphide core. Biochem. J. 340, 569-577.
25. Selman M. (1998). Hypersensitivity pneumonitis. In: Interstitial Lung Disease (Schwarz M. I. and King T. E., Jr., ed.). B. C. Decker Inc., Hamilton, 393-422.
26. Senior R. M. and Anthonisen N. R. (1998), Chronic obstructive pulmonary disease (COPD). Am. J. Respir. Crit. Care Med. 157, S139-S147.
27. Sherman M. P. (1997). Macrophage function in bacterial and fungal infections of newborns. In: Lung Macrophages and Dendritic Cells in Health and Disease (Lipscomb M. F. and Russell S. W., ed.). Marcel Dekker, Inc., New York, 409-436.
28. Simpson A. J., Maxwell A. I., Govan J. R., Haslett C., and Sallenave J.-M. (1999), Elafin (elastase-specific inhibitor) has anti-microbial activity against gram-positive and gram-negative respiratory pathogens. FEBS Lett. 452, 309-313.
29. Song X., Zeng L., Jin W., Thompson J., Mizel D. E., Lei K., Billinghurst R. C., Poole A. R., and Wahl S. M. (1999), Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis. J. Exp. Med. 190, 535-542.
30. Suzuki Y., Furukawa M., Abe J., Kashiwagi M., and Hirose S. (2000), Localization of porcine trappin-2 (SKALP/elafin) in trachea and large intestine by in situ hybridization and immunohistochemistry. Histochem. Cell Biol. 114, 15-20.
31. Suzumori N., Sato M., Yoneda T., Ozaki Y., Takagi H., and Suzumori K. (1999), Expression of secretory leukocyte protease inhibitor in women with endometriosis. Fertil. Steril. 72, 857-867.
32. Takeyabu K., Nishimura M., Betsuyaku T., Tanino M., Nagai K., Miyamoto K., and Kawakami Y. (2000), Increased level of SLPI in alveolar macrophages from subjects with subclinical emphysema (Abstract). Am. J. Crit. Care Respir. Med. 161, A872.
33. Tomee J. F. C., Koeter G, Hiemstra P. S., and Kauffman H. F. (1998), Secretory leukoprotease inhibitor: a native antimicrobial protein presenting a new therapeutic option? Thorax 53, 114-116.
34. 2 by alveolar macrophages in experimental allergic alveolitis. Microbiol. Immunol. 35, 147-155.
35. Tremblay G. M., Sallenave J.-M., Israël-Assayag E., Cormier Y., and Gauldie J. (1996), Elafin/elastase-specific inhibitor in bronchoalveolar lavage of normal subjects and farmer's lung. Am. J. Respir. Crit. Care Med. 154, 1092-1098.
36. Yuan Z. A., Soprano K. J., and Kueppers F. (1992), Alpha-1 antitrypsin response of stimulated alveolar macrophages. J. Cell Biochem. 49, 410-416.
37. 2, and matrix metalloproteinases. J. Clin. Invest. 99, 894-900.